Osi Systems OSIS

NASDAQ OSIS

$201.01 -3.24 (-1.58%)

As of: Sep 9, 2026 · 10:37 AM EDT

Key Stats

Market Cap3.34 Bn

P/E21.62

P/S1.87

Div. Yield0.00

Total Debt (Qtr)1.00 Bn

Revenue Growth (1y) (Qtr)-4.14

Add ratio to table…

About

OSI Systems, Inc. designs and manufactures specialized systems and components for critical applications in security, healthcare, and industrial inspection. The company serves customers worldwide by providing products that enhance safety, improve diagnostic capabilities, and increase manufacturing efficiency. Its core activities include the development of security screening equipment, medical imaging systems, and optoelectronic devices. OSI Systems, Inc. invests in research and development to advance imaging technologies and to expand its product portfolio. The firm operates from multiple locations across North America, Europe, and Asia, supporting a global supply chain and local customer support.

Revenue is generated primarily through the sale of finished systems, components, and related service contracts. The company's security segment sells baggage and personnel screening systems, cargo inspection systems, and vehicle screening equipment to transportation and government clients. Its healthcare segment provides diagnostic imaging systems, patient monitoring equipment, and surgical imaging solutions to hospitals and clinics. The optoelectronics and manufacturing segment supplies laser diodes, photodetectors, fiber optic components, and custom optoelectronic subsystems to defense, aerospace, and telecom customers. Service revenue comes from installation, maintenance, training, and warranty agreements associated with the sold products. A portion of sales is derived from aftermarket sales of spare parts and consumables.

The company operates through the following segments: Security, Healthcare, and Optoelectronics and Manufacturing.

Security: This segment develops and markets X ray based inspection systems, computed tomography scanners, and metal detection devices for airports, borders, and critical infrastructure facilities. It also provides cargo screening systems, vehicle inspection systems, and portable detection units for law enforcement and military applications. The segment focuses on delivering high throughput detection with low false alarm rates to support security operations.
Healthcare: This segment provides diagnostic imaging systems, patient monitoring equipment, and surgical imaging solutions to hospitals, clinics, and ambulatory care centers. It offers products such as ultrasound systems, electrocardiogram monitors, and fetal Doppler devices. The segment emphasizes ease of use, reliability, and cost effectiveness to help clinicians improve patient outcomes.
Optoelectronics and Manufacturing: This segment designs and manufactures laser diodes, photodetectors, fiber optic components, and related optoelectronic subsystems for defense, aerospace, and telecommunications applications. It also produces custom optical assemblies, laser modules, and sensor packages that meet stringent environmental and performance standards. The segment leverages its expertise in semiconductor fabrication and optical coating to serve both government contracts and commercial markets.

OSI Systems, Inc. holds a strong position in the global security inspection market where it competes with companies such as Smiths Detection, L3Harris Technologies, and Analogic Corporation. Its competitive advantages include proprietary imaging technology, a broad product portfolio that addresses multiple threat detection needs, and a worldwide service network that ensures rapid response and support. The company maintains an extensive intellectual property portfolio that includes patents on detection algorithms and detector designs. In the healthcare market, the company differentiates itself through reliable patient monitoring devices and cost effective imaging solutions that serve both large hospital systems and smaller clinical facilities. Its focus on regulatory compliance and product safety helps to build trust with healthcare providers.

The company serves a diverse customer base that includes federal agencies, state and local law enforcement, international airport authorities, hospital networks, outpatient clinics, and industrial manufacturers requiring optoelectronic components. It also supplies products to foreign governments, international organizations, and private enterprises involved in critical infrastructure protection. Long term relationships with key customers are supported by dedicated account teams and localized service centers. The firm's reputation for quality and on time delivery contributes to repeat business and contract renewals.

Investment Thesis

▲ Bull case

OSI Systems is positioned for sustained growth driven by its Security division's expanding backlog and turnkey service capabilities, which provide recurring revenue streams and high-margin opportunities that the market may be underestimating. The company closed Q1 FY25 with a backlog near an all-time high of $1.8 billion, and recent news confirms continued momentum with a $19 million NII systems order in North America and a $15 million task order from a U.S. government customer, both including follow-on service and support. These awards underscore the strength of OSI's turnkey model, which integrates civil works, systems integration, and long-term maintenance—creating sticky customer relationships and predictable cash flow beyond initial hardware sales. Management highlighted during the Q&A that service revenue growth is expected to accelerate as newly installed systems roll off warranty, a dynamic not yet fully reflected in current guidance. With over 70% of debt now fixed following the convertible note issuance and interest rate swap, OSI has reduced interest rate sensitivity while maintaining liquidity to fund strategic initiatives. The Security division's ability to leverage its global manufacturing footprint in the U.S., Mexico, U.K., India, Indonesia, and Malaysia to serve customers seeking alternatives to China-centric supply chains represents a structural tailwind that is underappreciated, particularly as geopolitical risks drive nearshoring trends. This vertical integration allows OSI to control costs, ensure quality, and respond rapidly to customer needs—advantages that compound over time as the company wins larger, multi-year contracts like the ongoing SEDENA and Uruguay programs. The market may be overlooking how these turnkey projects serve as loss leaders that unlock decades of service revenue, creating a compounding effect on profitability that is not captured in short-term EPS estimates.
The Optoelectronics and Manufacturing division is experiencing a quiet but significant inflection point driven by defense and aerospace demand, which management acknowledged during the Q&A as a growing pipeline despite softness in medical and consumer OEM markets. The division reported 8% external revenue growth in Q1 FY25, with a notable $5 million order for advanced optical sensors destined for complex navigation and guidance systems—an order size described as relatively large for this segment. Management emphasized that the Opto division benefits from a globally diversified manufacturing base and strong visibility into defense demand, which is being amplified by global unrest and increased requirements for optoelectronic components in surveillance and navigation equipment. This defense-driven tailwind is structural rather than cyclical, as it stems from enduring geopolitical tensions and modernization efforts across allied nations. Unlike the more volatile consumer tech cycle, defense spending tends to be multi-year and budget-locked, providing OSI with a stable, high-margin revenue stream that is less susceptible to inventory corrections. The company's nearshoring strategy in Mexico is also proving advantageous here, as OEMs seek to de-risk supply chains while maintaining proximity to U.S. defense contractors. While the Healthcare division showed only flat Q1 sales, management noted improved profitability from a streamlined infrastructure and highlighted its differentiation through proprietary software like The Rothman Index and safe and sound patient alarm management—assets that could drive margin expansion as healthcare providers prioritize predictive analytics and workflow efficiency. The market may be underestimating the combined impact of these defensive, software-enabled growth drivers across Opto and Healthcare, which could deliver steady, high-quality earnings growth even if Security experiences temporary softness.
The recent convertible debt financing and share repurchase program represent an underappreciated capital allocation strategy that is enhancing long-term shareholder value through reduced cost of capital and increased earnings per share accretion. By issuing $350 million in convertible notes at a 2.25% coupon due in FY30 and using proceeds to pay down higher-cost borrowings, OSI reduced its weighted average cost of debt while simultaneously repurchasing approximately 531,000 shares—an action that was immediately accretive to non-GAAP EPS. Management explicitly stated this transaction was "immediately accretive" due to interest cost reduction and lower share count, yet the market may not be fully pricing in the multi-year benefit of this lower-interest debt structure. With over 70% of debt now fixed, the company is insulated from rising rate risks that could pressure peers with floating-rate exposure. This financial flexibility allows OSI to pursue strategic acquisitions—like the RF-based technology bolt-on—without compromising balance sheet strength, and the guidance increase was partly attributed to this deal's earnings contribution. The RF acquisition, while not a major revenue driver in FY25, adds complementary technology that serves the same defense and security customers, enabling cross-selling opportunities and leveraging OSI's global sales and service infrastructure. Management's repeated emphasis on "one plus one must make more than two" signals a disciplined M&A approach focused on strategic fit and synergies, which could unlock hidden value as the acquired RF business scales through OSI's broader customer base. The market may be viewing this as a minor tactical move, but it reflects a broader capability to augment the core Security portfolio with adjacent technologies that increase customer stickiness and wallet share—particularly in military communications, space, and surveillance applications where OSI already has deep relationships. This strategic layering of technology, combined with a fortress-like balance sheet, creates optionality that is not reflected in current valuation multiples.

OSI Systems is positioned for sustained growth driven by its Security division's expanding backlog and turnkey service capabilities, which provide recurring revenue streams and high-margin opportunities that the market may be underestimating. The company closed Q1 FY25 with a backlog near an all-time high of $1.8 billion, and recent news confirms continued momentum with a $19 million NII systems order in North America and a $15 million task order from a U.S. government customer, both including follow-on service and support. These awards underscore the strength of OSI's turnkey model, which integrates civil works, systems integration, and long-term maintenance—creating sticky customer relationships and predictable cash flow beyond initial hardware sales. Management highlighted during the Q&A that service revenue growth is expected to accelerate as newly installed systems roll off warranty, a dynamic not yet fully reflected in current guidance. With over 70% of debt now fixed following the convertible note issuance and interest rate swap, OSI has reduced interest rate sensitivity while maintaining liquidity to fund strategic initiatives. The Security division's ability to leverage its global manufacturing footprint in the U.S., Mexico, U.K., India, Indonesia, and Malaysia to serve customers seeking alternatives to China-centric supply chains represents a structural tailwind that is underappreciated, particularly as geopolitical risks drive nearshoring trends. This vertical integration allows OSI to control costs, ensure quality, and respond rapidly to customer needs—advantages that compound over time as the company wins larger, multi-year contracts like the ongoing SEDENA and Uruguay programs. The market may be overlooking how these turnkey projects serve as loss leaders that unlock decades of service revenue, creating a compounding effect on profitability that is not captured in short-term EPS estimates.
The Optoelectronics and Manufacturing division is experiencing a quiet but significant inflection point driven by defense and aerospace demand, which management acknowledged during the Q&A as a growing pipeline despite softness in medical and consumer OEM markets. The division reported 8% external revenue growth in Q1 FY25, with a notable $5 million order for advanced optical sensors destined for complex navigation and guidance systems—an order size described as relatively large for this segment. Management emphasized that the Opto division benefits from a globally diversified manufacturing base and strong visibility into defense demand, which is being amplified by global unrest and increased requirements for optoelectronic components in surveillance and navigation equipment. This defense-driven tailwind is structural rather than cyclical, as it stems from enduring geopolitical tensions and modernization efforts across allied nations. Unlike the more volatile consumer tech cycle, defense spending tends to be multi-year and budget-locked, providing OSI with a stable, high-margin revenue stream that is less susceptible to inventory corrections. The company's nearshoring strategy in Mexico is also proving advantageous here, as OEMs seek to de-risk supply chains while maintaining proximity to U.S. defense contractors. While the Healthcare division showed only flat Q1 sales, management noted improved profitability from a streamlined infrastructure and highlighted its differentiation through proprietary software like The Rothman Index and safe and sound patient alarm management—assets that could drive margin expansion as healthcare providers prioritize predictive analytics and workflow efficiency. The market may be underestimating the combined impact of these defensive, software-enabled growth drivers across Opto and Healthcare, which could deliver steady, high-quality earnings growth even if Security experiences temporary softness.
The recent convertible debt financing and share repurchase program represent an underappreciated capital allocation strategy that is enhancing long-term shareholder value through reduced cost of capital and increased earnings per share accretion. By issuing $350 million in convertible notes at a 2.25% coupon due in FY30 and using proceeds to pay down higher-cost borrowings, OSI reduced its weighted average cost of debt while simultaneously repurchasing approximately 531,000 shares—an action that was immediately accretive to non-GAAP EPS. Management explicitly stated this transaction was "immediately accretive" due to interest cost reduction and lower share count, yet the market may not be fully pricing in the multi-year benefit of this lower-interest debt structure. With over 70% of debt now fixed, the company is insulated from rising rate risks that could pressure peers with floating-rate exposure. This financial flexibility allows OSI to pursue strategic acquisitions—like the RF-based technology bolt-on—without compromising balance sheet strength, and the guidance increase was partly attributed to this deal's earnings contribution. The RF acquisition, while not a major revenue driver in FY25, adds complementary technology that serves the same defense and security customers, enabling cross-selling opportunities and leveraging OSI's global sales and service infrastructure. Management's repeated emphasis on "one plus one must make more than two" signals a disciplined M&A approach focused on strategic fit and synergies, which could unlock hidden value as the acquired RF business scales through OSI's broader customer base. The market may be viewing this as a minor tactical move, but it reflects a broader capability to augment the core Security portfolio with adjacent technologies that increase customer stickiness and wallet share—particularly in military communications, space, and surveillance applications where OSI already has deep relationships. This strategic layering of technology, combined with a fortress-like balance sheet, creates optionality that is not reflected in current valuation multiples.

▼ Bear case

OSI Systems faces significant execution risk in converting its substantial backlog into timely revenue, particularly given the milestone-dependent billing structure on large international contracts that elevates receivables and distorts cash flow economics—a dynamic management acknowledged but did not fully mitigate in its outlook. The company reported $37 million of cash used in operations in Q1 FY25 due to higher inventories and receivables supporting Security division growth, with DSO elevated due to unbilled receivables on contracts like the SEDENA and Uruguay programs where billing is tied to customer milestone sign-off. While management stated this is "normal course for large government contracts" and that cash economics remain sound, the reality is that prolonged delays in customer acceptance or milestone completion could delay revenue recognition and strain working capital, especially if multiple large contracts experience simultaneous delays. The backlog of $1.8 billion (now $1.9 billion per Q3 FY26 news) represents future revenue, but the conversion rate is uncertain and dependent on factors outside OSI's control, including government funding cycles, geopolitical stability, and customer readiness to accept systems. During the Q&A, when asked about risks delaying opportunities, Deepak Chopra dismissed concerns by citing ongoing unrest in the Middle East and Ukraine as not weakening the pipeline—a response that may overlook how such conflicts could actually disrupt logistics, delay customs clearance, or divert government priorities away from long-term security investments. The company's reliance on a few mega-contracts (e.g., the $500 million-plus SEDENA deal and $200 million-plus international cargo contract) creates concentration risk; any setback on these programs could disproportionately impact revenue and margins. Furthermore, the shift toward turnkey services, while promising long-term service revenue, increases upfront execution complexity and exposure to civil works delays, permitting issues, and local labor constraints—factors that are harder to manage than pure product shipments.
The Optoelectronics and Manufacturing division's growth is vulnerable to customer inventory corrections and OEM demand cycles, particularly in the medical and consumer technology sectors, where management admitted softness persists and expects inventory rightsizing to continue into Q2 FY25. Although the division reported 8% external revenue growth in Q1 FY25, management cautioned that this number will "moderate" as they move into Q2 due to ongoing inventory adjustments by customers, signaling near-term headwinds that could undermine full-year expectations. The division's margin was negatively impacted by foreign exchange headwinds, and while operating income increased outside of FX effects, the reliance on favorable currency movements to flatter performance introduces volatility. More critically, the Opto division's success is tied to the capital expenditure cycles of its OEM customers in aerospace, defense, and medical—industries that are prone to multi-year delays in program approvals and budget allocations. While defense demand is growing, it is not immune to political shifts or budget sequestration, and the company's exposure to international OEMs means it remains susceptible to global economic slowdowns that could delay factory expansions or automation investments. The nearshoring initiative in Mexico, while strategically sound, is still ramping up and may not yet deliver the cost savings or supply chain resilience needed to offset higher logistics costs or quality control challenges associated with a fragmented global footprint. Without a clear acceleration in external demand beyond defense, the Opto division risks becoming a marginal contributor to overall growth, especially if Healthcare continues to underperform and Security faces backlog conversion delays.
OSI Systems' aggressive capital allocation—particularly the convertible debt financing and share repurchases—may be masking underlying organic growth weakness and creating future financial rigidity that could limit strategic flexibility. While the $350 million convertible note offering reduced interest costs and was accretive in the short term, it adds significant debt to the balance sheet ($998.7 million in long-term debt as of March 31, 2026 per Q3 FY26 news) that must be serviced or refinanced, potentially at less favorable rates if market conditions change. The company's net leverage of 2.3 (as stated in the transcript) leaves little room for error, and any downturn in Security or Opto performance could pressure covenant compliance or force a shift from growth investments to debt servicing. The share repurchase, while boosting EPS, deployed capital that might have been better used to reduce debt further or fund organic R&D initiatives—especially given that Healthcare's R&D spending is critical for next-generation patient monitoring solutions, yet the division showed only flat Q1 sales. Management's guidance increase was partly attributed to the acquisition's contribution, but the bolt-on RF deal is expected to be only modestly accretive in FY25, raising questions about the organic strength of the core business. If the market begins to question the sustainability of the Security division's growth—particularly as the lap anniversaries of the $500 million and $200 million contracts approach and year-over-year comparisons become tougher—the reliance on financial engineering to support EPS could unravel. Additionally, the CEO's impending retirement at the end of calendar 2024 introduces leadership transition risk; while Deepak Chopra will remain as Executive Chairman, the search for a successor could create uncertainty, and any misstep in appointing a leader capable of maintaining the company's vertically integrated model and global execution capabilities could erode competitive advantages built over decades.

OSI Systems faces significant execution risk in converting its substantial backlog into timely revenue, particularly given the milestone-dependent billing structure on large international contracts that elevates receivables and distorts cash flow economics—a dynamic management acknowledged but did not fully mitigate in its outlook. The company reported $37 million of cash used in operations in Q1 FY25 due to higher inventories and receivables supporting Security division growth, with DSO elevated due to unbilled receivables on contracts like the SEDENA and Uruguay programs where billing is tied to customer milestone sign-off. While management stated this is "normal course for large government contracts" and that cash economics remain sound, the reality is that prolonged delays in customer acceptance or milestone completion could delay revenue recognition and strain working capital, especially if multiple large contracts experience simultaneous delays. The backlog of $1.8 billion (now $1.9 billion per Q3 FY26 news) represents future revenue, but the conversion rate is uncertain and dependent on factors outside OSI's control, including government funding cycles, geopolitical stability, and customer readiness to accept systems. During the Q&A, when asked about risks delaying opportunities, Deepak Chopra dismissed concerns by citing ongoing unrest in the Middle East and Ukraine as not weakening the pipeline—a response that may overlook how such conflicts could actually disrupt logistics, delay customs clearance, or divert government priorities away from long-term security investments. The company's reliance on a few mega-contracts (e.g., the $500 million-plus SEDENA deal and $200 million-plus international cargo contract) creates concentration risk; any setback on these programs could disproportionately impact revenue and margins. Furthermore, the shift toward turnkey services, while promising long-term service revenue, increases upfront execution complexity and exposure to civil works delays, permitting issues, and local labor constraints—factors that are harder to manage than pure product shipments.
The Optoelectronics and Manufacturing division's growth is vulnerable to customer inventory corrections and OEM demand cycles, particularly in the medical and consumer technology sectors, where management admitted softness persists and expects inventory rightsizing to continue into Q2 FY25. Although the division reported 8% external revenue growth in Q1 FY25, management cautioned that this number will "moderate" as they move into Q2 due to ongoing inventory adjustments by customers, signaling near-term headwinds that could undermine full-year expectations. The division's margin was negatively impacted by foreign exchange headwinds, and while operating income increased outside of FX effects, the reliance on favorable currency movements to flatter performance introduces volatility. More critically, the Opto division's success is tied to the capital expenditure cycles of its OEM customers in aerospace, defense, and medical—industries that are prone to multi-year delays in program approvals and budget allocations. While defense demand is growing, it is not immune to political shifts or budget sequestration, and the company's exposure to international OEMs means it remains susceptible to global economic slowdowns that could delay factory expansions or automation investments. The nearshoring initiative in Mexico, while strategically sound, is still ramping up and may not yet deliver the cost savings or supply chain resilience needed to offset higher logistics costs or quality control challenges associated with a fragmented global footprint. Without a clear acceleration in external demand beyond defense, the Opto division risks becoming a marginal contributor to overall growth, especially if Healthcare continues to underperform and Security faces backlog conversion delays.
OSI Systems' aggressive capital allocation—particularly the convertible debt financing and share repurchases—may be masking underlying organic growth weakness and creating future financial rigidity that could limit strategic flexibility. While the $350 million convertible note offering reduced interest costs and was accretive in the short term, it adds significant debt to the balance sheet ($998.7 million in long-term debt as of March 31, 2026 per Q3 FY26 news) that must be serviced or refinanced, potentially at less favorable rates if market conditions change. The company's net leverage of 2.3 (as stated in the transcript) leaves little room for error, and any downturn in Security or Opto performance could pressure covenant compliance or force a shift from growth investments to debt servicing. The share repurchase, while boosting EPS, deployed capital that might have been better used to reduce debt further or fund organic R&D initiatives—especially given that Healthcare's R&D spending is critical for next-generation patient monitoring solutions, yet the division showed only flat Q1 sales. Management's guidance increase was partly attributed to the acquisition's contribution, but the bolt-on RF deal is expected to be only modestly accretive in FY25, raising questions about the organic strength of the core business. If the market begins to question the sustainability of the Security division's growth—particularly as the lap anniversaries of the $500 million and $200 million contracts approach and year-over-year comparisons become tougher—the reliance on financial engineering to support EPS could unravel. Additionally, the CEO's impending retirement at the end of calendar 2024 introduces leadership transition risk; while Deepak Chopra will remain as Executive Chairman, the search for a successor could create uncertainty, and any misstep in appointing a leader capable of maintaining the company's vertically integrated model and global execution capabilities could erode competitive advantages built over decades.

Product and Service Breakdown of Revenue (2026)

Peer group

Peer Comparison

Companies in the Defense

S.No.	Ticker	Company	match	Market Cap	P/E	P/S	Total Debt (Qtr)
1	LMT	Lockheed Martin Corp	primary	121.41 Bn	19.31	1.58	20.54 Bn
2	GD	General Dynamics Corp	primary	95.28 Bn	21.23	1.74	7.52 Bn
3	MSI	Motorola Solutions, Inc.	primary	76.81 Bn	35.89	6.28	9.65 Bn
4	NOC	Northrop Grumman Corp /De/	primary	73.70 Bn	16.39	1.72	14.43 Bn
5	LHX	L3Harris Technologies, Inc. /De/	primary	47.32 Bn	13.88	1.21	11.00 Bn
6	ESLT	Elbit Systems Ltd	primary	32.70 Bn	51.42	3.83	0.18 Bn
7	TDY	Teledyne Technologies Inc	primary	27.93 Bn	28.64	4.38	2.03 Bn
8	CW	Curtiss Wright Corp	primary	20.95 Bn	38.71	5.73	1.16 Bn

Osi Systems OSIS

About

Investment Thesis

Segments Breakdown of Revenue (2026)

Product and Service Breakdown of Revenue (2026)

Peer Comparison

Create an account

Sign In

Reset Password